Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
10,500
16% diarrhea and poor insurance coverage. Zetia provides the same LDL reductions without side effects. Your best reductions are from Statins, if you can take them.
DAR- Joint pain is listed as Arthralgia 2.3% and placebo is 1%. That is the only Adverse Reaction listed in package insert having a greater than 2% incidence of occurring.
RAF: I have seen your question go both ways. UHC as well as other payers design formularies according to what the employer wants. Not two UHC employers always have the same benefits therefore how UHC would respond to your question is not the same. Some UHC employer plans will allow another year without lab work and another will require lab work. Should they deny Vascepa because Trigs not over treatment threshold the prescriber would have to write in the prior-auth patient’s trigs are at goal due to being on Vascepa and without treatment would be outside of healthy range and at risk.
Thanks Gbert! I appreciate your comments
GBERT- Pitavastatin 1mg= 31% reduction in LDL greater than 10mg or 20mg Pravastatin
Prava 10mg 22%, Prava 20mg 29%, Prava 40mg 34%
Pitva 1mg 31%, Pitava 2mg 39%, Pitvava 4mg 45%
I would move Pitva above Prava and agree with other rankings
HDG- quote me correctly please
I am talking about a written Rx for Vascepa processed by UHC, not someone without insurance or electing to not use their drug benefits. UHC having a Prior Auth requirement will limit automatic switches to generic options. Currently switching across the board is happening without checks and balances unless provider states Dispense as Written on the Rx. ‘Fake’ refers to anything but Vascepa when prescribed for reduce-It indications
HDG- indication for Reduce It- population in study were on a statin, United Healthcare’s electronic system would indicate PA, verification patient on a statin and Vascepa approved. Physician wrote Vascepa Rx, without UHC requiring PA, pharmacy could do a generic switch without physician’s approval and patient getting worthless fake substitute without physician knowing until follow-up visit
AARP is covered under United Healthcare. When UHC makes decisions, their actions are noticed by other payers and employer groups. This is very positive and says a lot about UHC’s understanding efficiency and outcomes for Vascepa and reductions in heart attacks, strokes and death. UHC can save employers lots of dollars keeping employees healthy. Making sure providers use Vascepa with known outcomes will help UHC show cost savings and growing their own book of business.
I’m willing to join others & vote to get someone or 2 or 3 on the board! We need a new look and a new spark!
I’’m in too BB
Sts66, I just watched the video and, to me, they are smiling because they feel good, feel protected and what side effects? It they, or their provider, look up side effects, only ONE reported, >2% is Arthralgia “joint pain’ at 2.3% and placebo was 1%. Find me another medication with that side effect profile & a 25% reduction when taken with a statin, also with p value of p.00000001! Find me any drug when taken with a statin that does not have the potential to cause added side effects. I for one have missed seeing smiling faces, maybe that is why I liked it, no mask hiding happiness.
I did the exact same thing! All “No” except for accounting firm. The only voice I have at this time is my vote. It is time to act not just chat on a message board!!
Prayers for you and your family!
JL! This post explains why I read your posts. Making the truth known about Vascepa and SI is the golden Key that will unlock health and wealth for those who get this underlying reason Vascepa works verses all the other Fibrates/Niacin trying to connect Trig reduction to reduction in events...never worked, never proven BECAUSE it is Systemic Inflammation thus... only 21 patients needed to treat to see these results! NO OTHER OUTCOMES STUDY HAS THIS!!!
Thanks JL I appreciate your contribution to this board.
Sick inappropriate Ads for sure! Glad to see someone stand up and say something. Thank You for being Courageous being blessed with a moral compass!
Sick inappropriate Ads for sure! Glad to see someone stand up and say something. Thank You for being Courageous being blessed with a moral compass!
Easy... if someone is able to drink from their mouth,, put the 4g in your mouth and drink from a straw! Makes Vascepa quicker to go down than the time to complain about the capsule size. Hospitals use this technique when they administer meds regardless of size or quantity. Try it!
Vascepa being Gold Standard will Drive Rx Growth.... Vascepa direct to consumer TV ads with specific words, pictures, telling the story of Vascepa being the Only Prescription Medication with proven Death Reductions, Stroke Reductions, Heart Attack Reduction, these results were not shown in generics. Patients want what they see and KNOW works. Patients have never been specifically told about Vascepa. AZ is a Pharma Lord...BECAUSE OF THEIR VERY EFFECTIVE DTC MARKETING! Providers WILL prescribe what patients ask for. The only Pure EPA with indication for claims in the DTC will be Vascepa. LOTS OF MONEY to be made. Trust the user, they will come with effective marketing. Vascepa on majority of formularies and covered because of the indication. Patient ask for Vascepa, Prescriber prescribes because patient asked, Managed Care pays because it is indicated. Many PPIs came after Prilosec however, everyone knew and asked for “The Purple Pill.” Marketing moves and being the Gold Standard drives Rx for a long time.
SurgeGuy2.0 sorry you shorted AMRN, its a clinical thing that is going to save lives, not your financial status. Talk to your provider, Vascepa may very well extend your life too! Best wishes to a long life :)
Jammaalish- I find your link interesting. Review Vascepa's package insert for adverse events reported with over a 3% occurrence....there are NONE. That is way studies are done with large populations to see adverse reaction percentages. Such complaints are recorded and taken very serious; however, all have been under 3%. It would be hard to find another prescription with that safety profile!! Provider's review package insert data, not internet post. There are patients who have adverse reactions to Placebo, this is just how it goes. Can you find another FDA approved labeled cardiovascular risk reduction medication with a cleaner side effect profile??? Nope!
Reducing Plaque Blockage or Reducing Inflammation, this has been the question for ever!! Maybe a reduction in inflammation increase vascular structure to prevent vascular cap from breaking off and causing events... even if plaque is present and prevents additional plaque from forming??? Reduce-It showed true reductions in MACE in a remarkable way- only seen with Lipit or when it entered the Cardiovascular market. Evaporate showed in a few months Vascepa slowed progression of plaque and put the mineral oil placebo concern to rest... It continues to support what Vascepa is all about. It is hard for folks to understand because IT IS SOMETHING NOT SEEN OR HEARD ABOUT BEFORE IN CARDIOVASCULAR HEALTH when discussing highly refined Fish Oil (back up the small yellow bus, lots of folks want to jump on and ride around before Vascepa's Cliff Notes are printed)
sts66: Thanks for your help! I appreciate your comments on this board and your clinical insight. I make sure to read your remarks -Pharmagirl
Thanks for your help here guys! I have been an Vascepa believer for many years, like most on this board. I saw the science- Vascepa is Beyond the Lipids, it is systemic inflammation Reducer and/or Reconstruction of vascular integrity, doing all the heavy lifting! I've been a holder of stock for a long time due to it's clinical potential in MANY systems, not just cardiovascular. Inflammation is the root cause of ALL chronic diseases. This is a wonderful drug discovery and will make a HUGE impact on many lives in many ways for years to come.
Placed $200 sell limit on all my AMRN stock held with investment company in order to keep "them" from using my AMRN stock to manipulate the market with put options. Unsure why I have not done this already and SO MUCH encourage other longs to do the same to keep their stock from being used while it sits in their funds. Having assigned it a position, it is not available.